Quadrant Capital Group’s BeOne Medicines Ltd. American Depositary Shares ONC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $630K | Buy |
2,604
+2,377
| +1,047% | +$575K | 0.02% | 730 |
|
2025
Q1 | $61.8K | Buy |
227
+18
| +9% | +$4.9K | ﹤0.01% | 1649 |
|
2024
Q4 | $38.6K | Buy |
209
+67
| +47% | +$12.4K | ﹤0.01% | 1560 |
|
2024
Q3 | $31.9K | Buy |
142
+79
| +125% | +$17.7K | ﹤0.01% | 1696 |
|
2024
Q2 | $8.99K | Sell |
63
-23
| -27% | -$3.28K | ﹤0.01% | 2153 |
|
2024
Q1 | $13.5K | Sell |
86
-28
| -25% | -$4.38K | ﹤0.01% | 1996 |
|
2023
Q4 | $20.6K | Sell |
114
-1
| -0.9% | -$180 | ﹤0.01% | 1812 |
|
2023
Q3 | $20.7K | Buy |
115
+3
| +3% | +$540 | ﹤0.01% | 1696 |
|
2023
Q2 | $20K | Sell |
112
-2
| -2% | -$357 | ﹤0.01% | 1716 |
|
2023
Q1 | $24.6K | Buy |
114
+4
| +4% | +$862 | ﹤0.01% | 1586 |
|
2022
Q4 | $24.2K | Buy |
110
+63
| +134% | +$13.9K | ﹤0.01% | 1569 |
|
2022
Q3 | $6K | Buy |
47
+26
| +124% | +$3.32K | ﹤0.01% | 2107 |
|
2022
Q2 | $3K | Sell |
21
-16
| -43% | -$2.29K | ﹤0.01% | 2160 |
|
2022
Q1 | $7K | Sell |
37
-258
| -87% | -$48.8K | ﹤0.01% | 1818 |
|
2021
Q4 | $80K | Sell |
295
-19
| -6% | -$5.15K | 0.01% | 749 |
|
2021
Q3 | $114K | Buy |
314
+88
| +39% | +$31.9K | 0.02% | 573 |
|
2021
Q2 | $78K | Buy |
226
+41
| +22% | +$14.2K | 0.01% | 692 |
|
2021
Q1 | $64K | Sell |
185
-55
| -23% | -$19K | 0.01% | 727 |
|
2020
Q4 | $62K | Sell |
240
-68
| -22% | -$17.6K | 0.01% | 685 |
|
2020
Q3 | $88K | Buy |
308
+136
| +79% | +$38.9K | 0.02% | 466 |
|
2020
Q2 | $32K | Sell |
172
-952
| -85% | -$177K | 0.01% | 892 |
|
2020
Q1 | $139K | Buy |
1,124
+961
| +590% | +$119K | 0.02% | 471 |
|
2019
Q4 | $25K | Sell |
163
-185
| -53% | -$28.4K | ﹤0.01% | 1643 |
|
2019
Q3 | $42K | Sell |
348
-147
| -30% | -$17.7K | 0.01% | 1297 |
|
2019
Q2 | $60K | Buy |
495
+131
| +36% | +$15.9K | 0.01% | 1136 |
|
2019
Q1 | $47K | Buy |
364
+207
| +132% | +$26.7K | 0.01% | 1263 |
|
2018
Q4 | $22K | Buy |
+157
| New | +$22K | 0.01% | 1156 |
|